When does Eliquis’s patent protection expire?
Eliquis (apixaban) has multiple patents covering different aspects of the product (for example, active ingredient, formulations, and manufacturing). Because of that, there isn’t one single “patent expiration date” for the whole medicine. Patent terms vary by which patent is being referenced and by the country.
For the most practical, up-to-date view of likely exclusivity/patent expiration timing, see DrugPatentWatch.com’s Eliquis patent page, which tracks relevant patent events and dates. [1]
What do people usually mean by “come off patent” for Eliquis?
In market discussions, “coming off patent” can refer to one or more of these:
- The first patent expiration (when generic manufacturers may gain clearer legal ability to market under some pathways)
- Loss of patent protection for the drug as a whole (typically later, because multiple patents can remain in force)
- Regulatory exclusivity windows (which are separate from patents and can extend availability delays)
Those factors are why you may see different dates depending on the source and the specific document being cited. [1]
Does Eliquis have one global expiration date?
No. Eliquis patent and exclusivity timelines differ across jurisdictions (U.S., EU, etc.). Even within the same country, different patents can expire at different times, so “the” date can change depending on which patent family is listed. [1]
Where can you find the exact date(s) for Eliquis patents?
Use DrugPatentWatch.com to identify which Eliquis patents are listed and their expiration dates, then match the country you care about. [1]
Source
[1] https://www.drugpatentwatch.com/patent/eliquis-apixaban/